These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 18165266)

  • 21. Defective immunoglobulin A (IgA) glycosylation and IgA deposits in patients with IgA nephropathy.
    Kolka R; Valdimarsson H; Bodvarsson M; Hardarson S; Jonsson T
    APMIS; 2013 Sep; 121(9):890-7. PubMed ID: 23398317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.
    Hiki Y; Odani H; Takahashi M; Yasuda Y; Nishimoto A; Iwase H; Shinzato T; Kobayashi Y; Maeda K
    Kidney Int; 2001 Mar; 59(3):1077-85. PubMed ID: 11231363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mesangial proliferative glomerulonephritis].
    Yamada A
    Nihon Rinsho; 2004 Oct; 62(10):1842-6. PubMed ID: 15500128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical characterization of glomerular IgA deposits in IgA nephropathy.
    Suzuki S; Kobayashi H; Sato H; Arakawa M
    Clin Nephrol; 1990 Feb; 33(2):66-71. PubMed ID: 2107051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SPAK plays a pathogenic role in IgA nephropathy through the activation of NF-κB/MAPKs signaling pathway.
    Lin TJ; Yang SS; Hua KF; Tsai YL; Lin SH; Ka SM
    Free Radic Biol Med; 2016 Oct; 99():214-224. PubMed ID: 27519267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective role of anti-synthetic hinge peptide antibody for glomerular deposition of hypoglycosylated IgA1.
    Hiki Y; Takahashi K; Shimozato S; Odani H; Yamamoto K; Tomita M; Hasegawa M; Murakami K; Nabeshima K; Nakai S; Fujita Y; Ishida I; Iwase H; Sugiyama S
    Clin Exp Nephrol; 2008 Feb; 12(1):20-7. PubMed ID: 18175057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Insights into the Pathogenesis of IgA Nephropathy.
    Robert T; Berthelot L; Cambier A; Rondeau E; Monteiro RC
    Trends Mol Med; 2015 Dec; 21(12):762-775. PubMed ID: 26614735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunopathology of glomerulonephritis with mesangial IgA deposits].
    Berthoux FC
    Nephrologie; 1989; 10(4):169-74. PubMed ID: 2699007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoelectron microscopic studies of immune complex deposits and basement membrane components in IgA nephropathy.
    Woodrow DF; Shore I; Moss J; Gower P; Phillips M
    J Pathol; 1989 Jan; 157(1):47-57. PubMed ID: 2921666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glomerular deposition of complex-forming glycoprotein heterogenous in charge (protein HC) in IgA nephropathy.
    Imai H; Wakui H; Ishino T; Komatsuda A; Nakamoto Y; Miura AB; Kobayashi R
    Clin Nephrol; 1992 Apr; 37(4):169-76. PubMed ID: 1374693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of mesangial complement in the hematuria of experimental IgA nephropathy.
    Emancipator SN; Ovary Z; Lamm ME
    Lab Invest; 1987 Sep; 57(3):269-76. PubMed ID: 3306149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of macromolecular IgA in IgA nephropathy.
    van der Boog PJ; van Kooten C; de Fijter JW; Daha MR
    Kidney Int; 2005 Mar; 67(3):813-21. PubMed ID: 15698421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extrarenal cytokines modulate the glomerular response to IgA immune complexes.
    Montinaro V; Hevey K; Aventaggiato L; Fadden K; Esparza A; Chen A; Finbloom DS; Rifai A
    Kidney Int; 1992 Aug; 42(2):341-53. PubMed ID: 1405317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Formation of IgA deposits in Berger's disease: what we learned from animal models].
    Berthelot L; Monteiro RC
    Biol Aujourdhui; 2013; 207(4):241-7. PubMed ID: 24594572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glomerular immune deposits in experimental IgA nephropathy. A continuum of circulating and in situ formed immune complexes.
    Chen A; Wong SS; Rifai A
    Am J Pathol; 1988 Jan; 130(1):216-22. PubMed ID: 3276211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histology and immunohistology of IgA nephropathy.
    Haas M
    J Nephrol; 2005; 18(6):676-80. PubMed ID: 16358224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The endogenous immune response modulates the course of IgA-immune complex mediated nephropathy.
    Chao TK; Rifai A; Ka SM; Yang SM; Shui HA; Lin YF; Sytwu HK; Lee WH; Kung JT; Chen A
    Kidney Int; 2006 Jul; 70(2):283-97. PubMed ID: 16738538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compositional similarity between immunoglobulins binding to asialo-, agalacto-IgA1-Sepharose and those deposited in glomeruli in IgA nephropathy.
    Takatani T; Iwase H; Itoh A; Nakamura I; Hayashi M; Sakamoto H; Kamata K; Kobayashi Y; Hiki Y; Okamoto M; Higashihara M
    J Nephrol; 2004; 17(5):679-86. PubMed ID: 15593035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IgA deposits might not influence the production of extracellular matrix in glomeruli of ddY mice, a spontaneous animal model for IgA nephropathy.
    Tsushima Y; Tomino Y; Shimizu M; Ohmuro H; Takeuchi K; Kuramoto T; Shirato I; Koide H
    Nephron; 1994; 66(1):81-6. PubMed ID: 7906404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disposition of IgA-containing circulating immune complexes.
    Hebert LA
    Am J Kidney Dis; 1988 Nov; 12(5):388-92. PubMed ID: 3055964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.